RAPT Therapeutics SG&A Expense (TTM) Insights

RAPT Therapeutics Inc (RAPT)

2.80 +0.08 (+2.94%) USD | NASDAQ | Jul 05, 16:00

2.80 0.00 (0.00%) After-Hours: 17:51

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	27.81M
December 31, 2023	26.06M
September 30, 2023	24.58M
June 30, 2023	22.77M
March 31, 2023	21.48M
December 31, 2022	20.24M
September 30, 2022	19.75M
June 30, 2022	18.45M
March 31, 2022	16.77M
December 31, 2021	16.04M
September 30, 2021	15.03M

Date	Value
June 30, 2021	14.45M
March 31, 2021	13.49M
December 31, 2020	12.77M
September 30, 2020	11.91M
June 30, 2020	10.45M
March 31, 2020	10.34M
December 31, 2019	8.724M
September 30, 2019	7.39M
June 30, 2019	7.021M
March 31, 2019	5.797M
December 31, 2018	5.18M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

7.39M

Minimum

Sep 2019

27.81M

Maximum

Mar 2024

16.76M

Average

16.04M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks